Satellite Symposium - Assessing Fracture Risk: the Future for Designing New Therapies

5 May 2010, Florence, Italy.
The Osteoporotic Virtual Physiological Human (VPHOP) Consortium organizes a symposium entitled "Assessing fracture risk: the future for designing new therapies" which will be held during the IOF WCO-ECCEO10 Congress in Florence, Italy. The symposium will take place in Hall B, Spadolini Pavillion - Fortezza da Basso, Viale Filippo Strozzi 1. The event will provide an opportunity to present the clinical community the early results of the VPHOP project on the new technology to fight osteoprosis.

The symposium program aims to present to the clinical experts the state of the art in technologies to assess the risk of fractures in patients affected by osteoporosis.

Moderators of the symposium will be the VPHOP Project Coordinator, Marco Viceconti and the chair of the VPHOP Clinical Committee, Renè Rizzoli.

The program of the event is the following:

  • 14:00-14:15 Renè Rizzoli (Geneva University Hospital): The role of technology in the fight against osteoporosis
  • 14:15-14:30 Dieter Felsenberg (Charité, Berlin): Clinical prospectives on osteoporosis: bone and muscle
  • 14:30-14:45 Fulvia Taddei (Istituto Ortopedico Rizzoli, Bologna): New technologies to predict the risk of fracture
  • 15:00-15:15 Bert van Rietbergen (Technical University Eindhoven): Tissue level imaging for critical risk assessment
  • 14:45-15:00 Ralph Müller (ETH Zurich): Cell and tissue based simulation of osteoporosis and pharmacological treatment
  • 15:15-15:30 Marco Viceconti (Istituto Ortopedico Rizzoli, Bologna): Personalised, predictive, and integrative medicine: future scenarios for osteoporosis

To attend the satellite symposium you have to be registered to the International Osteoporosis Foundation (IOF) World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - http://www.iofwco-ecceo10.org
Florence, May 5-8, 2010

For further information, please visit: http://www.vphop.eu

About the Osteoporotic Virtual Physiological Human (VPHOP)
VPHOP is a Collaborative Integrated Project that is developing simulation-based technology to predict the risk of bone fracture in osteoporosis patients. Co-funded by the European Commission as part of the Seventh Framework Program. The project runs for four years starting from September 2008. Coordinated by Rizzoli Orthopaedic Institute, the Project Consortium gathers 19 European Organisations based in Italy, The Netherlands, Germany, Switzerland, Belgium, France, United Kingdom, Sweden, and Iceland.

For more information: http://www.vphop.eu.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...